GlaxoSmithKline plc (GSK)

NYSE - NYSE Real Time Price. Currency in USD
41.43-0.06 (-0.14%)
At close: 4:02 PM EDT

41.43 0.00 (0.00%)
After hours: 4:02 PM EDT

People also watch:
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Prev Close41.49
Bid41.45 x 5300
Ask41.46 x 10300
Day's Range41.09 - 41.60
52wk Range37.82 - 45.58
1y Target EstN/A
Market Cap103.77B
P/E Ratio (ttm)2,589.38
Avg Vol (3m)2,668,806
Dividend & Yield1.87 (4.50%)
Earnings DateN/A
Trade prices are not sourced from all markets
  • Better Buy: Pfizer Inc. vs. GlaxoSmithKline plc
    Motley Fool6 hours ago

    Better Buy: Pfizer Inc. vs. GlaxoSmithKline plc

    Which of these two big pharma dividend stocks is the better choice for long-term investors?

  • TheStreet.com8 hours ago

    These 5 Big-Cap Stocks Are Breaking Out After the Debate: Alphabet, Visa and More

    As the dust settles on Wednesday's contentious presidential debate, U.S. markets are actually teetering on the edge of breakout territory.

  • Reutersyesterday

    WHO seeks new mechanism for crisis vaccine supplies at low cost

    The World Health Organization, drugmakers and humanitarian groups are hammering out details of a new vaccine supply system aimed at getting vital shots to vulnerable people in crises such as wars or natural disasters. The mechanism, which so far has British drugmaker GlaxoSmithKline signed up to provide its pneumonia vaccine at the lowest possible price, will ask other major pharmaceutical firms including Pfizer and Merck to make similar cut-price agreements for emergencies only. "The idea is that this will set a model in place for other manufacturers to put their vaccines on the table," said Greg Elder, a medical coordinator with the international charity Medecins Sans Frontieres (MSF) which joined talks on the issue at the WHO's Geneva headquarters last week.